Pro-life campaign bankroller leans on senators to block FDA nominee unless abortion pill restricted
Susan B. Anthony Pro-Life America also wants a revised methodology for the mifepristone safety review the FDA has been allegedly slow-walking for more than a year and says it won't finish until spring 2027.
Read →